Introduction
CHD represents a formidable challenge in global public health, maintaining a persistently high disease burden. Epidemiological evidence reveals that CHD not only occupies a preeminent position within the global spectrum of cardiovascular diseases but also contributes significantly to morbidity and mortality rates.1 Projections indicate that by 2035, CHD is anticipated to account for approximately 32% of global mortality.2 Notably, contemporary studies demonstrate a discernible downward tendency in CHD incidence within developed nations,3 primarily attributed to the rigorous implementation of evidence-based primary and secondary preventive strategies.4 This epidemiological transition underscores the imperative of early disease detection through advanced diagnostic modalities. Consequently, there exists an…